Friday, May 20, 2022
No Result
View All Result
Medical Finance
  • Home
  • News
  • Interviews
  • Mediknowledge
  • Insights From Industry
  • Thought Leaders
  • Coronavirus
  • Whitepapers
  • Home
  • News
  • Interviews
  • Mediknowledge
  • Insights From Industry
  • Thought Leaders
  • Coronavirus
  • Whitepapers
No Result
View All Result
Medical Finance
No Result
View All Result
Home News

Grouping tumors by ‘immune archetypes’ points the way to personalized immunotherapies

by Medical Finance
in News
Grouping tumors by ‘immune archetypes’ points the way to personalized immunotherapies
9
SHARES
104
VIEWS
Share on FacebookShare on Twitter

The UCSF researchers, led by first co-authors Alexis Combes, PhD, and Bushra Samad, MS, and senior author, Max Krummel, PhD, obtained tumor specimens from 78 UCSF clinicians, and surveyed 364 tumors biopsies from patients and categorized them into groups based on their immune microenvironment. Their findings offer a new way of looking at cancer immunotherapy that matches the immune environment around the tumor and points the way to personalized immunotherapies.

This is a new framework for how to look at cancer patients. This work will help clinicians find the right biology to target and avoid targeting cells that aren’t present in the tumor.”


Alexis Combes, Director, D2B CoLab and Incoming Assistant Professor, Department of Pathology, UCSF

Immunotherapy for cancer treatment harnesses the body’s immune system to fight cancer. It has held great promise since it was first developed as a biological therapy used to treat a variety of cancers. While it has proven successful for some patients, immunotherapy does not work for all patients.

“We were driven by this question of why immunotherapies work for some people and not others,” said Krummel, Robert E. Smith Endowed Chair in Experimental Pathology and director of the Krummel Lab at UCSF. “It’s more complex than responders and non-responders. Our goal was to discern how many responses there are to these targeted therapies.”

Tumors have microenvironments

Tumors are more than just out-of-control cells. They are also filled with immune cells which are supposed to kill the cancer cells. But in cancer, malignant cells are able to overcome the body’s immune response and continue to multiply.

The research team found that a variety of cancers come in prescribed forms, each of which represents a unique subversion of the body’s immune defenses. The researchers characterized different microenvironments in the tumors, looking at which immune cells were present and which genes were expressed.

“We could see that the tumors and their environments inform each other,” said Combes.

The research team was able to group the tumors into 12 groups, which they call archetypes. To their surprise, the tumors contained a wide range of immune cells, such as macrophages, NK and B cells — beyond the T cells which are the focus of current immunotherapies.

Their research indicates that the immune archetype of a tumor is not necessarily tied to a type of cancer. Some archetypes are largely drawn from just a few kinds of cancer. Others draw from many. This means that some melanomas are quite similar to some lung tumors but more biologically different than other melanomas.

“Unbiased interrogation of multiple data sources including genetic sequencing, cell surface markers, imaging, and patient clinical data, set the groundwork atop which we were able to identify and describe these immune archetypes,” said Samad.

Identifying patients for clinical trials

The classification scheme not only identifies which tumors are likely to be vulnerable to current immunotherapies, it also helps identify which patients might be most responsive in which clinical trial.

“This framework allows us to eliminate a bunch of noise,” said Krummel. “We may have been targeting cells that weren’t even in the tumor.”

Clinicians and researchers contribute knowledge

Krummel’s research team was able to bring together a large group of UCSF researchers and clinicians – 78 in all – who lent expertise across disciplines. The authors came together with the common goal of better leveraging promising therapies. This dual viewpoint and large body of knowledge is an approach being fostered by UCSF’s CoLabs.

“This is just the beginning of this project,” said Krummel. “We believe this is the next step in personalized medicine for cancer therapy. When the immunotherapy you design can thus be placed against the correct biology. That biology may not always go by a name we’ve heretofore known. Archetypes, we think, are those names.”

Source:

University of California – San Francisco

Journal reference:

Combes, A. J., et al. (2021) Discovering dominant tumor immune archetypes in a pan-cancer census. Cell. doi.org/10.1016/j.cell.2021.12.004

Total
0
Shares
Share 0
Tweet 0
Pin it 0
Share 0
Medical Finance

Medical Finance

Related Posts

New cryo-EM method may be able to shortcut a big step in modern vaccine development

New system enables automatic analysis of biomedical videos captured by microscopy

by Medical Finance
May 20, 2022
0

Researchers at the Universidad Carlos III de Madrid (UC3M) have developed a system based on computer vision techniques that allows...

Horizontal gene transfer between viruses and hosts plays a major role in driving evolution

First unbiased proteome scale study expands the number of known transcriptional activators

by Medical Finance
May 20, 2022
0

Also known as transcriptional activators for their ability to induce transcription of genes into RNA messages, these proteins are essential...

Scientists unravel how blood cells mount the first line of defense against viruses

Molecular cage helps researchers to get atomic-level details of key cancer protein

by Medical Finance
May 20, 2022
0

Acute myeloid leukemia (AML), the American Cancer Institute estimates, will affect more than 20,000 Americans this year and kill more...

Study demonstrates how the transcription factor C/EBPβ can positively influence fat storage

Study demonstrates how the transcription factor C/EBPβ can positively influence fat storage

by Medical Finance
May 20, 2022
0

The chronic nutritional and metabolic disease of obesity is characterized by an excessive increase in body fat and its accumulation...

Rapid DNA sequencing technique used to diagnose rare genetic disease in short time

Compounds used to fight fungal diseases in plants may be driving antimicrobial resistance

by Medical Finance
May 20, 2022
0

New research from the University of Georgia has shown, for the first time, that compounds used to fight fungal diseases...

Horizontal gene transfer between viruses and hosts plays a major role in driving evolution

Defective mitochondrial DNA could be modified using gene-editing techniques

by Medical Finance
May 20, 2022
0

Defective mitochondria – the 'batteries' that power the cells of our bodies – could in future be repaired using gene-editing...

Next Post
What are the benefits of Irish Life Sciences’ new 2.2 mL square well ‘V’ bottom plate?

Combating infectious diseases with reagent banks

New research may help better understand the causes of human diseases

0 0 votes
Article Rating
Subscribe
Login
Notify of
guest
guest
0 Comments
Inline Feedbacks
View all comments

Support

  • Contact
  • Disclaimer
  • Home
  • Privacy Policy
  • Terms And Conditions

Categories

  • Coronavirus
  • Insights From Industry
  • Interviews
  • Mediknowledge
  • News
  • Thought Leaders
  • Whitepapers

More News

  • Study: Comorbidities Diminish the Likelihood of Seropositivity After SARS-CoV-2 Vaccination. Image Credit: Design_Cells / Shutterstock
    Association between seropositivity and comorbidities after COVID-19 vaccination
  • Illustration of the iQue® spheroid T cell killing assay principles.
    Assessing the function and phenotype of T-cells in a spheroid T-cell killing assay
  • Home
  • Privacy Policy
  • Contact
  • Disclaimer
  • Terms And Conditions

© 2022 Medical Finance - Latest Financial and Business News

No Result
View All Result
  • Interviews
  • Mediknowledge
  • News
  • Insights From Industry
  • Coronavirus
  • Thought Leaders
  • Whitepapers
wpDiscuz
0
0
Would love your thoughts, please comment.x
()
x
| Reply